Ghent University Academic Bibliography

Your filters: cql: author="Lapouble, Eve" or (type any "bookEditor issueEditor" and editor="Lapouble, Eve")

Add to list
- Journal Article
- A1
- open access
Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)

Angela Bellini, Ulrike Pötschger, Virginie Bernard, Eve Lapouble, Sylvain Baulande, Peter F. Ambros, Nathalie Auger, Klaus Beiske, Marie Bernkopf, David R. Betts, et al.

(2021) JOURNAL OF CLINICAL ONCOLOGY. 39(30). p.3377-3390
Add to list
- Journal Article
- A1
- open access
Genomic amplifications and distal 6q loss : novel markers for poor survival in high-risk neuroblastoma patients

Pauline Depuydt, Valentina Boeva, Toby D Hocking, Robrecht Cannoodt (UGent) , Inge M Ambros, Peter F Ambros, Shahab Asgharzadeh, Edward F Attiyeh, Valérie Combaret, Raffaella Defferrari, et al.

(2018) JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 110(10).
Add to list
- Conference Paper
- C3
Identification of novel, rare markers for poor survival in high-risk neuroblastoma patients by merging and reanalysing existing datasets

Pauline Depuydt, Valentina Boeva, Toby Hocking, Robrecht Cannoodt (UGent) , Inge Ambros, Peter Ambros, Shahab Asgharzadeh, Edward Attiyeh, Valérie Combaret, Raffaella Defferrari, et al.

(2017) Big Data in Biology and Health, Abstracts.
Add to list
- Conference Paper
- C3
Genomic amplifications and distal 6q loss are novel markers for poor survival in high-risk neuroblastoma patients

Pauline Depuydt, Valentina Boeva, Toby D Hocking, Robrecht Cannoodt (UGent) , Inge M Ambros, Peter F Ambros, Shahab Asgharzadeh, Edward F Attiyeh, Valérie Combaret, Raffaella Defferrari, et al.

(2017) Cancer Genomics, 3rd EACR conference, Abstracts.
Add to list
Emergence of new ALK mutations at relapse of neuroblastoma

Gudrun Schleiermacher, Niloufar Javanmardi, Virginie Bernard, Quentin Leroy, Julie Cappo, Thomas Rio Frio, Gaëlle Pierron, Eve Lapouble, Valérie Combaret, Franki Speleman (UGent) , et al.

(2014) JOURNAL OF CLINICAL ONCOLOGY. 32(25). p.2727-2734

Academic Bibliography

Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)

Genomic amplifications and distal 6q loss : novel markers for poor survival in high-risk neuroblastoma patients

Identification of novel, rare markers for poor survival in high-risk neuroblastoma patients by merging and reanalysing existing datasets

Genomic amplifications and distal 6q loss are novel markers for poor survival in high-risk neuroblastoma patients

Emergence of new ALK mutations at relapse of neuroblastoma

Contents

Support

Contact